N-Acetyl Cysteine as an Add-on Therapy is Useful in Treating Acute Lumbar Radiculopathy Caused by Disc Herniation: Results of a Randomized, Controlled Clinical Trial

医学 Oswestry残疾指数 安慰剂 可视模拟标度 腰痛 止痛药 随机对照试验 麻醉 腰椎 坐骨神经痛 背痛 临床试验 神经病理性疼痛 物理疗法 外科 内科学 替代医学 病理
作者
Bijan Heidari,Zeinab-Alsadat Seyedian,Maryam Mehrpooya,Davoud Ahmadimoghaddam,Mahtabalsadat Mirjalili,Masood Ghiasian
出处
期刊:Reviews on Recent Clinical Trials [Bentham Science Publishers]
卷期号:18 (4): 288-299 被引量:3
标识
DOI:10.2174/0115748871250545230919055109
摘要

BACKGROUND: Available experimental and clinical evidence indicates that N-Acetyl cysteine (NAC) may have an analgesic role in specific pain conditions, particularly neuropathic pain. Thus, we hypothesized that NAC supplementation might be also helpful in decreasing pain and improving pain-related disability in patients with acute radiculopathy. We designed this study to investigate the potential use of NAC-adjunctive treatment to Nonsteroidal Anti- Inflammatory Drugs (NSAIDs) in patients with acute radiculopathy secondary to lumbar intervertebral disc herniation. METHODS: Sixty-two patients diagnosed with acute lumbar radiculopathy associated with disc herniation were randomly allocated to the NAC or the placebo groups. Besides naproxen at a dose of 500 mg twice a day, participants based on their allocation group started with NAC or matched placebo at a dose of 600 mg twice a day for eight weeks. The pain severity, measured by the Visual Analog Scale (VAS), and pain-related disability measured by the Oswestry Disability Index (ODI) were measured at baseline and weeks 2, 4, and 8 of treatment. Global improvement of symptoms rated by Patient and Clinical Global Impressions of Change (PGIC and CGIC) was also recorded at the end of week 8. All analyses were conducted on an Intentionto- Treat (ITT) analysis data set. RESULTS: A comparison of the VAS and ODI scores at weeks 2 and 4 of the treatment between the two groups did not show a significant difference. In contrast, from week 4 to week 8, we noticed a significantly greater reduction in the mean VAS and ODI scores in the NAC group compared to the placebo group (p-value <0.001 for both variables). In parallel with these results, also, more NAC-treated than placebo-treated patients achieved treatment success defined as ''very much'' or ''much improved'' on CGIC and PGIC scales, and these differences reached a significant level (p-value = .011 and p-value = .043). CONCLUSIONS: This study suggested that NAC might be a relevant candidate for adjunct therapy in managing acute lumbar radiculopathy. Additional clinical trials are needed to validate these findings.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
2秒前
酷波er的应助被任性的幼菱采纳,获得10
2秒前
科目三的应助被99v587采纳,获得10
2秒前
初景的应助被兜兜采纳,获得20
3秒前
ming完成签到,获得积分10
3秒前
3秒前
4秒前
史文韬发布了新的文献求助10
4秒前
科研通AI6.3的应助被大方的契采纳,获得10
5秒前
5秒前
不管啦发布了新的文献求助10
5秒前
5秒前
无敌大裤衩完成签到,获得积分10
6秒前
CT完成签到,获得积分10
6秒前
7秒前
愚者发布了新的文献求助10
7秒前
纪秋完成签到 ,获得积分10
8秒前
Ellalala完成签到 ,获得积分10
8秒前
CipherSage的应助被师专第一黑奴采纳,获得10
9秒前
9秒前
9秒前
9秒前
科研通AI6.2的应助被Waitcy采纳,获得10
9秒前
霸气乐菱发布了新的文献求助10
10秒前
10秒前
11秒前
彩色青亦发布了新的文献求助10
11秒前
11秒前
果冻完成签到 ,获得积分10
12秒前
13秒前
14秒前
xushuqi给xushuqi的求助进行了留言
14秒前
cloudss完成签到,获得积分10
15秒前
勿语发布了新的文献求助10
16秒前
自信易槐完成签到,获得积分10
16秒前
Zhang发布了新的文献求助10
16秒前
科研通AI6.3的应助被dudu采纳,获得10
16秒前
17秒前
自由的百川完成签到 ,获得积分10
17秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Handbook of Sport Coaching Research 1000
Orthognathic Surgery - 2 Volume Set 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8194415
求助须知:如何正确求助?哪些是违规求助? 9580155
关于积分的说明 21870088
捐赠科研通 7793967
什么是DOI,文献DOI怎么找? 3437647
关于科研通互助平台的介绍 2560986
邀请新用户注册赠送积分活动 2484376